| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.09. | Innovation in Oncology: The Synergy of New and Old Drugs | ||
| 23.09. | Pelago Unveils New Behavioral Health Platform for Substance Use, Mental Health and Behavioral Addiction Care | ||
| 22.09. | How is Oracle Health's Nurse AI Agent Different? | ||
| 22.09. | Amgen Drug Meets Goals of Key Test in Common Autoimmune Disease With No Approved Meds | ||
| 22.09. | AI Workers Need a Probation Period, Not Just a Pilot | ||
| 21.09. | Radiopharmaceutical Dealmaking Continues With Telix's $1.65B ITM Acquisition | ||
| 21.09. | Array Behavioral Care Unveils New Triage Model | ||
| 21.09. | How AI Is Transforming Clinical Documentation at Intermountain Health | ||
| 21.09. | The Nurse Is Health Care's Most Underpriced Founder | ||
| 21.09. | Electra's Upsized IPO Lands $350M for New Class of Precision Immunology Drugs | ||
| 21.09. | Angle Health Raises $600M to Grow Employer Health Benefits Platform | ||
| 20.09. | RFK Jr. Overhauls USPSTF Leadership: 5 Things to Know | ||
| 20.09. | Two Years After the Change Healthcare Cyberattack, Healthcare Still Has a Clearinghouse Redundancy Problem | ||
| 20.09. | The Trials Were Always There - Patients Just Couldn't Find Them | ||
| 18.09. | Ayble Health Secures $16M for Virtual Digestive Health Clinic | ||
| 18.09. | Ultragenyx Gene Therapy Is First Approved Treatment for Rare Neuro Disease Sanfilippo | ||
| 18.09. | CMS Broadens ACCESS Model to New Chronic Conditions | ||
| 18.09. | Extending ADHD Coverage for the Entire Active Day | ||
| 18.09. | The Shifting Role of Wearables in Healthcare | ||
| 18.09. | Trump's $500 ACA Refunds: 'We Shouldn't Confuse a Check With a Healthcare Affordability Strategy' | ||
| 17.09. | North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug | ||
| 17.09. | How a Cancer Diagnosis Shaped This VC's Precision Health Thesis | ||
| 17.09. | The Missing Link in Surgical Safety: Integrating Patient Warming and Positioning | ||
| 16.09. | Novartis Gains a Way to Get Drugs Into the Brain, Buying Sironax Tech for $125M | ||
| 16.09. | As MA Denial Rates Rise, Hospitals Are Betting on Traditional Medicare Instead |